Posted as supplied by author.
Web References
W1
Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: The Whickham Survey. Clin Endocrinol (Oxf) 1977;7:481-93.W2
Holm IA, Manson JE, Michels KB, Alexander EK, Willett WC, Utiger RD. Smoking and other lifestyle factors and the risk of Graves’ hyperthyroidism. Arch Intern Med 2005;165:1606-11.W3
Vestergaard P. Smoking and thyroid disorders – a meta-analysis. Eur J Endocrinol 2002;146:153-61.W4
Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 1990;89(5):602-8.W5
Hamburger JI. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab 1980;50(6):1089-93.W6
Mariotti S, Martino E, Cupini C. Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia. N Engl J Med 1982;307:410-2.W7
McDougall IR: In vivo radionuclide tests and imaging. In Braverman LE, Utiger RD (eds): Werner and Ingbar’s The Thyroid, ed 9. Philadelphia, JB Lippincott, 2005, pp 309-28.W8
Liaw YF, Huang MJ, Fan KD, Li KL, Wu SS, Chen TJ. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med 1993;118(6):424-8.W9
Williams KV, Nayak S, Becker D, Reyes J, Burmeister LA. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab 1997;82(6):1727-33.W10
Braga M, Cooper DS. Clinical review 129: Oral cholecystographic agents and the thyroid. J Clin Endocrinol Metab 2001;86(5):1853-60.W11
Cooper DS. Antithyroid drugs in the management of patients with Graves’ disease: An evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab 2003;88:3474-81.W12
Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 1998;83(2):685-7.W13
Vanderpump MPJ, Ahlquist JAO, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 1996:313;539-44.